1.Development of a Chinese version of the Stress Adaption Scale and the assessment of its reliability and validity among Chinese patients with multimorbidity.
Yujia FU ; Jingjie WU ; Binyu ZHAO ; Chuyang LAI ; Erxu XUE ; Dan WANG ; Manjun WANG ; Leiwen TANG ; Jing SHAO
Journal of Zhejiang University. Medical sciences 2023;52(3):361-370
OBJECTIVES:
To develop a Chinese version of the Stress Adaption Scale (SAS) and to assess its reliability and validity among Chinese patients with multimorbidity.
METHODS:
The Brislin model was used to translate, synthesize, back-translate, and cross culturally adapt the SAS. A total of 323 multimorbidity patients selected by convenience sampling method from four hospitals in Zhejiang province. The critical ratio method, total question correlation method, and graded response model (item characteristic curve and item discrimination) were used for item analysis. Cronbach's alpha coefficient and split-half reliability were used for the reliability analysis. Content validity analysis, structural validity analysis, and criterion association validity analysis were performed by expert scoring method, confirmatory factor analysis, and Pearson correlation coefficient method, respectively.
RESULTS:
The Chinese version of the SAS contained 2 dimensions of resilience and thriving, with a total of 10 items. In the item analysis, the critical ratio method showed that the critical ratio of all items was greater than 3.0 (P<0.001); the correlation coefficient method showed that the Pearson correlation coefficients for all items exceeded 0.4 (P<0.01). The graded response model showed that items of the revised scale exhibited distinct item characteristic curves and all items had discrimination parameters exceeding 1.0. In the reliability analysis, Cronbach's alpha coefficient of the revised Chinese version of the SAS scale was 0.849, and the split-half reliability was 0.873. In the validity analysis, the item-level content validity index and scale-level content validity index both exceeded 0.80. In the confirmatory factor analysis, the revised two-factor model showed satisfactory fit indices (χ2/df=3.115, RMSEA=0.081, RMR=0.046, GFI=0.937, AGFI=0.898, CFI=0.936, TLI=0.915). In the criterion-related validity analysis, the Chinese version of the SAS score was negatively correlated with the Perceived Stress Scale and the Treatment Burden Questionnaire, with correlation coefficients of -0.592 and -0.482, respectively (both P<0.01).
CONCLUSIONS
The Chinese version of the SAS has good reliability and validity, which can be used to evaluate the stress adaption capacity among multimorbidity patients in China, and provides a reference for developing individualized health management measures.
Humans
;
Adaptation, Psychological
;
Asian People
;
China
;
Multimorbidity
;
Reproducibility of Results
;
Stress, Psychological/psychology*
;
Surveys and Questionnaires
;
Translating
;
Cross-Cultural Comparison
2.Clinical photoacoustic imaging platforms.
Wonseok CHOI ; Eun Yeong PARK ; Seungwan JEON ; Chulhong KIM
Biomedical Engineering Letters 2018;8(2):139-155
Photoacoustic imaging (PAI) is a new promising medical imaging technology available for diagnosing and assessing various pathologies. PAI complements existing imaging modalities by providing information not currently available for diagnosing, e.g., oxygenation level of the underlying tissue. Currently, researchers are translating PAI from benchside to bedside to make unique clinical advantages of PAI available for patient care. The requirements for a successful clinical PAI system are; deeper imaging depth, wider field of view, and faster scan time than the laboratory-level PAI systems. Currently, many research groups and companies are developing novel technologies for data acquisition/signal processing systems, detector geometry, and an acoustic sensor. In this review, we summarize state-of-the-art clinical PAI systems with three types of the imaging transducers: linear array transducer, curved linear array transducer, and volumetric array transducer. We will also discuss the limitations of the current PAI systems and describe latest techniques being developed to address these for further enhancing the image quality of PAI for successful clinical translation.
Acoustics
;
Complement System Proteins
;
Diagnostic Imaging
;
Oxygen
;
Pathology
;
Patient Care
;
Transducers
;
Translating
3.Connecting Technological Innovation in Artificial Intelligence to Real-world Medical Practice through Rigorous Clinical Validation: What Peer-reviewed Medical Journals Could Do.
Seong Ho PARK ; Herbert Y KRESSEL
Journal of Korean Medical Science 2018;33(22):e152-
Artificial intelligence (AI) is projected to substantially influence clinical practice in the foreseeable future. However, despite the excitement around the technologies, it is yet rare to see examples of robust clinical validation of the technologies and, as a result, very few are currently in clinical use. A thorough, systematic validation of AI technologies using adequately designed clinical research studies before their integration into clinical practice is critical to ensure patient benefit and safety while avoiding any inadvertent harms. We would like to suggest several specific points regarding the role that peer-reviewed medical journals can play, in terms of study design, registration, and reporting, to help achieve proper and meaningful clinical validation of AI technologies designed to make medical diagnosis and prediction, focusing on the evaluation of diagnostic accuracy efficacy. Peer-reviewed medical journals can encourage investigators who wish to validate the performance of AI systems for medical diagnosis and prediction to pay closer attention to the factors listed in this article by emphasizing their importance. Thereby, peer-reviewed medical journals can ultimately facilitate translating the technological innovations into real-world practice while securing patient safety and benefit.
Artificial Intelligence*
;
Decision Support Techniques
;
Diagnosis
;
Humans
;
Inventions*
;
Journalism, Medical
;
Machine Learning
;
Patient Safety
;
Peer Review
;
Research Personnel
;
Translating
4.Development of an Autism Subtyping Questionnaire Based on Social Behaviors.
Fan-Chao MENG ; Xin-Jie XU ; Tian-Jia SONG ; Xiao-Jing SHOU ; Xiao-Li WANG ; Song-Ping HAN ; Ji-Sheng HAN ; Rong ZHANG
Neuroscience Bulletin 2018;34(5):789-800
Autism spectrum disorder can be differentiated into three subtypes (aloof, passive, and active-but-odd) based on social behaviors according to the Wing Subgroups Questionnaire (WSQ). However, the correlations between the scores on some individual items and the total score are poor. In the present study, we translated the WSQ into Chinese, modified it, validated it in autistic and typically-developing Chinese children, and renamed it the Beijing Autism Subtyping Questionnaire (BASQ). Our results demonstrated that the BASQ had improved validity and reliability, and differentiated autistic children into these three subtypes more precisely. We noted that the autistic symptoms tended to be severe in the aloof, moderate in the passive, and mild in the active-but-odd subtypes. The modified questionnaire may facilitate etiological studies and the selection of therapeutic regimes.
Autism Spectrum Disorder
;
diagnosis
;
Child, Preschool
;
Factor Analysis, Statistical
;
Female
;
Humans
;
Male
;
Reproducibility of Results
;
Social Behavior
;
Surveys and Questionnaires
;
Translating
5.Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis.
Chiara CREMOLINI ; Carlotta ANTONIOTTI ; Filippo PIETRANTONIO ; Rosa BERENATO ; Marco TAMPELLINI ; Chiara BARATELLI ; Lisa SALVATORE ; Federica MARMORINO ; Beatrice BORELLI ; Federico NICHETTI ; Paolo BIRONZO ; Cristina SONETTO ; Maria DI BARTOLOMEO ; Filippo DE BRAUD ; Fotios LOUPAKIS ; Alfredo FALCONE ; Massimo DI MAIO
Cancer Research and Treatment 2017;49(3):834-845
PURPOSE: The purpose of this study was to evaluate progression-free survival (PFS) and objective response rate (ORR) as surrogate endpoints of overall survival (OS) in modern clinical trials investigating the efficacy of targeted agents in the second-line treatment of metastatic colorectal cancer (mCRC). MATERIALS AND METHODS: A systematic search of literature pertaining to randomized phase II and III trials evaluating targeted agents as second-line treatments for mCRC was performed. The strength of the correlation between both PFS and ORR and OS was assessed based on the Pearson's correlation coefficient (R) and the coefficient of determination (R²). RESULTS: Twenty trials, including a total of 7,571 patients, met the search criteria. The median duration of post-progression survival (PPS) was 7.6 months. The median differences between experimental and control arms were 0.65 months (range, –2.4 to 3.4) for the median PFS and 0.7 months (range, –5.8 to 3.9) for the median OS. PFS and ORR showed moderate (R=0.734, R²=0.539, p < 0.001) and poor correlation (R=0.169, R²=0.029, p=0.476) with OS, respectively. No differences between anti-angiogenic agents and other drugs were evident. CONCLUSION: Targeted agents investigated in the second-line treatment of mCRC provided minimal PFS gains translating into modest OS improvements. Considering both the moderate correlation between PFS and OS and the short duration of PPS, the OS should remain the preferred primary endpoint for randomized clinical trials in the second-line treatment of mCRC.
Arm
;
Biomarkers*
;
Colorectal Neoplasms*
;
Disease-Free Survival
;
Humans
;
Molecular Targeted Therapy
;
Translating
6.Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis.
Chiara CREMOLINI ; Carlotta ANTONIOTTI ; Filippo PIETRANTONIO ; Rosa BERENATO ; Marco TAMPELLINI ; Chiara BARATELLI ; Lisa SALVATORE ; Federica MARMORINO ; Beatrice BORELLI ; Federico NICHETTI ; Paolo BIRONZO ; Cristina SONETTO ; Maria DI BARTOLOMEO ; Filippo DE BRAUD ; Fotios LOUPAKIS ; Alfredo FALCONE ; Massimo DI MAIO
Cancer Research and Treatment 2017;49(3):834-845
PURPOSE: The purpose of this study was to evaluate progression-free survival (PFS) and objective response rate (ORR) as surrogate endpoints of overall survival (OS) in modern clinical trials investigating the efficacy of targeted agents in the second-line treatment of metastatic colorectal cancer (mCRC). MATERIALS AND METHODS: A systematic search of literature pertaining to randomized phase II and III trials evaluating targeted agents as second-line treatments for mCRC was performed. The strength of the correlation between both PFS and ORR and OS was assessed based on the Pearson's correlation coefficient (R) and the coefficient of determination (R²). RESULTS: Twenty trials, including a total of 7,571 patients, met the search criteria. The median duration of post-progression survival (PPS) was 7.6 months. The median differences between experimental and control arms were 0.65 months (range, –2.4 to 3.4) for the median PFS and 0.7 months (range, –5.8 to 3.9) for the median OS. PFS and ORR showed moderate (R=0.734, R²=0.539, p < 0.001) and poor correlation (R=0.169, R²=0.029, p=0.476) with OS, respectively. No differences between anti-angiogenic agents and other drugs were evident. CONCLUSION: Targeted agents investigated in the second-line treatment of mCRC provided minimal PFS gains translating into modest OS improvements. Considering both the moderate correlation between PFS and OS and the short duration of PPS, the OS should remain the preferred primary endpoint for randomized clinical trials in the second-line treatment of mCRC.
Arm
;
Biomarkers*
;
Colorectal Neoplasms*
;
Disease-Free Survival
;
Humans
;
Molecular Targeted Therapy
;
Translating
7.Reliability and Validity of the Korean Kessler Foundation Neglect Assessment Process.
Bo Ram KIM ; Eun Hwa JEONG ; Mooyeon OH-PARK ; Kyungjae LEE ; Hyuntae KIM ; Seung Don YOO ; Taeim YI ; MinYoung KIM ; Jongmin LEE
Brain & Neurorehabilitation 2017;10(2):e10-
OBJECTIVE: To develop the Korean version of the Kessler Foundation Neglect Assessment Process (KF-NAP), which enables a more functional assessment of unilateral spatial neglect, by first translating it into Korean and then statistically standardizing it. METHODS: Two rehabilitation specialists translated the KF-NAP into Korean. The entire process of administering the Korean KF-NAP to 30 patients with brain disease was video-recorded. Five occupational therapists from 4 university hospitals nationwide evaluated the 30 video-recorded examination cases. We analyzed inter- and intra-reliabilities of the Korean KF-NAP using the intraclass coefficient and Pearson correlation coefficient. Internal consistency reliability of the assessment categories was also examined using Cronbach's alpha coefficient. RESULTS: For the construct validation study, the Korean KF-NAP was strongly correlated with the Albert's test and letter cancellation test (r ≥ 0.8; p < 0.05). The intraclass correlation coefficients for the first and second assessments of the Korean KF-NAP were 0.973 and 0.982, respectively, showing high reliability (p < 0.05). The intra-rater reliabilities exceeded 0.9 (p < 0.05), and Cronbach's alpha coefficient exceeded 0.8, showing internal consistency reliability. CONCLUSION: The Korean KF-NAP is a reliable and valid instrument for assessing hemispatial neglect symptoms in patients with brain diseases.
Brain Diseases
;
Hospitals, University
;
Humans
;
Perceptual Disorders
;
Rehabilitation
;
Reproducibility of Results*
;
Specialization
;
Translating
;
Translations
8.Psychosometric properties of the Filipino version of the international consultation on incontinence questionnaire-male lower urinary tract symptoms and female lower urinary tract symptoms.
Chito M SEMBLANTE ; Marie Carmela M LAPITAN
Philippine Journal of Urology 2017;27(1):41-47
OBJECTIVE: The purpose of this study was to translate the International Consultation on Incontinence Questionnaire-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) and Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) into Filipino and determine its psychosometric properties mainly feasibility, internal consistency (reliability), and stability (test-retest reliability).
METHODS: This was an observational, non-interventionist study, which recruited 100 male and 100 female patients seeking consult at the Philippine General Hospital for lower urinary symptoms. The questionnaires were completed in a single visit with the exception of 20 patients who were asked to answer the questionnaire again after 2 weeks to evaluate test-retest reliability. The ICIQ-MLUTS Filipino questionnaire is a 14-item self-administered questionnaire while the ICIQ-FLUTS Filipino questionnaire is a 13-item self-administered questionnaire.
RESULTS: There was an 81% completion rate for the ICIQ-MLUTS questionnaire and 100% completion rate for the ICIQ-FLUTS questionnaire. Reliability testing revealed Cronbach's alpha coefficient of 0.949 for the ICIQ-MLUTS and 0.956 for the ICIQ-FLUTS questionnaire while test-retest reliability showed intraclass coefficient values above 0.9 for individual items of both questionnaires.
CONCLUSION: The Filipino versions of the ICIQ-MLUTS and ICIQ-FLUTS questionnaires show adequate feasibility, reliability and validity.
Human ; Male ; Female ; Hospitals, General ; Lower Urinary Tract Symptoms ; Referral And Consultation ; Reproducibility Of Results ; Surveys And Questionnaires ; Translating ; Urinary Incontinence
9.Validation of the Korean Version of the DN4 Diagnostic Questionnaire for Neuropathic Pain in Patients with Lumbar or Lumbar-Radicular Pain.
Ho Joong KIM ; Joon Hee PARK ; Didier BOUHASSIRA ; Jae Hoon SHIN ; Bong Soon CHANG ; Choon Ki LEE ; Chang Hyun BAEK ; Jin S YEOM
Yonsei Medical Journal 2016;57(2):449-454
PURPOSE: To evaluate the diagnostic value of the Korean version of the Douleur Neuropathique 4 (DN4) questionnaire and to validate this questionnaire in terms of psychometric properties in patients with chronic pain due to degenerative spinal disease. MATERIALS AND METHODS: The Korean version of the DN4 questionnaire, which was translated and linguistically validated by the MAPI Research Group, was tested on 83 patients with lumbar or lumbar-radicular pain. Test-retest reliability was evaluated in a subsample of 40 patients who completed two assessments with an interval of 2 weeks. Nociceptive pain and neuropathic component pain were diagnosed in 40 and 43 patients, respectively. RESULTS: The Cronbach's alpha coefficient of internal consistency was 0.819, and the test-retest intraclass correlation coefficient (3, 1) (95% confidence interval) was 0.813 (0.776-0.847) (n=40). The area under the receiver-operator characteristics curve was 0.953 (p<0.001), with 95% confidence interval between 0.869 and 0.990. The Korean version of the DN4 questionnaire showed a sensitivity of 100% and 87.1%, and a specificity of 88.2% and 94.1% at the cutoff value of 3/10 and 4/10, respectively, for discriminating neuropathic component pain. CONCLUSION: The present study demonstrated the good discriminatory power of DN4 between nociceptive pain and neuropathic component pain in patients with lumbar or lumbar-radicular pain.
Adult
;
Aged
;
Aged, 80 and over
;
Chronic Pain/*diagnosis
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neuralgia/*diagnosis
;
Pain Measurement/*methods
;
Psychometrics
;
Reproducibility of Results
;
Sensitivity and Specificity
;
Surveys and Questionnaires/*standards
;
Translating
10.Ultra-rare Disease and Genomics-Driven Precision Medicine.
Genomics & Informatics 2016;14(2):42-45
Since next-generation sequencing (NGS) technique was adopted into clinical practices, revolutionary advances in diagnosing rare genetic diseases have been achieved through translating genomic medicine into precision or personalized management. Indeed, several successful cases of molecular diagnosis and treatment with personalized or targeted therapies of rare genetic diseases have been reported. Still, there are several obstacles to be overcome for wider application of NGS-based precision medicine, including high sequencing cost, incomplete variant sensitivity and accuracy, practical complexities, and a shortage of available treatment options.
Diagnosis
;
Humans
;
Precision Medicine*
;
Rare Diseases
;
Translating


Result Analysis
Print
Save
E-mail